It’s Pharma’s new strategic frontier in a rapidly changing health dimension. As science and technology provide the advancement of therapies, public health systems and private industry have jointly to address the complex needs along the therapeutic pathway of stakeholders who fund, regulate, reimburse, prescribe and use the medicines Pharma companies produce. The key word of this new era is sustainability.